Exelon Corp Files 8-K: Regulation FD & Exhibits

Ticker: EXC · Form: 8-K · Filed: Nov 24, 2025 · CIK: 1109357

Exelon CORP 8-K Filing Summary
FieldDetail
CompanyExelon CORP (EXC)
Form Type8-K
Filed DateNov 24, 2025
Risk Levellow
Pages2
Reading Time3 min
Sentimentneutral

Sentiment: neutral

Topics: regulatory-disclosure, financial-reporting

Related Tickers: EXC

TL;DR

EXC files 8-K for Reg FD & exhibits. Standard reporting.

AI Summary

On November 18, 2025, Exelon Corporation filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specific financial figures or material events were detailed in the provided excerpt.

Why It Matters

This 8-K filing indicates Exelon Corporation is providing updates related to regulatory disclosures and financial exhibits, which are important for investors to monitor company compliance and financial reporting.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for regulatory disclosure and exhibits, with no immediate indication of significant negative events.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for Exelon Corporation?

The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.

On what date was this 8-K report filed?

The 8-K report was filed on November 24, 2025, with the earliest event reported being November 18, 2025.

What is Exelon Corporation's principal executive office address?

Exelon Corporation's principal executive offices are located at 10 South Dearborn Street, P.O. Box 805379, Chicago, Illinois 60680-5379.

What is Exelon Corporation's IRS Employer Identification Number?

Exelon Corporation's IRS Employer Identification Number is 23-2990190.

What is Exelon Corporation's Commission File Number?

Exelon Corporation's Commission File Number is 001-16169.

Filing Stats: 732 words · 3 min read · ~2 pages · Grade level 12.4 · Accepted 2025-11-24 16:12:10

Filing Documents

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. On November 18, 2025, the United States District Court for the Northern District of Illinois issued an order (the "Preliminary Approval Order") granting preliminary approval of the proposed settlement of a consolidated stockholder derivative action captioned In re Exelon Corporation Derivative Litigation , No. 1:21-cv-03611 (N.D. Ill.) (the "Consolidated Derivative Action"). As previously disclosed, this proposed settlement of the Consolidated Derivative Action was reached through mediation efforts by the Special Litigation Committee (the "SLC"), the Independent Review Committee of the Exelon Corporation (the "Company") Board of Directors (the "Board") (which had been formed in 2022 to ensure the Board's consideration of any SLC recommendations would be independent and objective), the Board, and certain of the derivative stockholders. The terms of the proposed settlement of the Consolidated Derivative Action are set forth in the Stipulation and Agreement of Settlement, attached hereto as Exhibit 99.2 and incorporated by reference herein. Pursuant to the Preliminary Approval Order, the Company is publishing the Notice of Pendency and Proposed Settlement of Consolidated Derivative Action, attached hereto as Exhibit 99.1 and incorporated by reference herein. The information set forth in and incorporated by reference into this Item 7.01 of this Current Report on Form 8-K is being furnished pursuant to Item 7.01 of Form 8-K and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any of the Company's filings under the Securities Act of 1933 or the Securities Exchange Act of 1934, whether made before or after the date hereof and regardless of any general incorporation language in such filings, except to the extent expressly set forth by specific reference in such a filing. The fu

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Notice of Proposed Settlement 99.2 Stipulation and Agreement of Settlement 104 Cover Page Interactive Data File (formatted as Inline XBRL)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, each Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. EXELON CORPORATION /s/ Colette D. Honorable Colette D. Honorable Executive Vice President, Chief Legal Officer and Corporate Secretary November 24, 2025 EXHIBIT INDEX Exhibit No. Description 99.1 Notice of Proposed Settlement 99.2 Stipulation and Agreement of Settlement 104 Cover Page Interactive Data File (formatted as Inline XBRL)

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing